RhumbLine Advisers’s Pliant Therapeutics PLRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3K	Hold	2,379	–	–	﹤0.01%	3910
2025 Q4	$2.9K	Hold	2,379	–	–	﹤0.01%	3959
2025 Q3	$3.52K	Hold	2,379	–	–	﹤0.01%	3940
2025 Q2	$2.76K	Sell	2,379 -87,315	-97%	-$123K	﹤0.01%	3967
2025 Q1	$121K	Sell	89,694 -2,886	-3%	-$17.5K	﹤0.01%	3319
2024 Q4	$1.22M	Sell	92,580 -2,117	-2%	-$28.9K	﹤0.01%	2143
2024 Q3	$1.06M	Sell	94,697 -1,791	-2%	-$22.4K	﹤0.01%	2238
2024 Q2	$1.04M	Buy	96,488 +14,662	+18%	+$189K	﹤0.01%	2221
2024 Q1	$1.22M	Buy	81,826 +1,212	+2%	+$20K	﹤0.01%	2142
2023 Q4	$1.46M	Buy	80,614 +1,517	+2%	+$23.1K	﹤0.01%	2072
2023 Q3	$1.37M	Buy	79,097 +255	+0.3%	+$4.42K	﹤0.01%	2038
2023 Q2	$1.43M	Buy	+78,842	New	+$1.87M	﹤0.01%	2097
2022 Q2	–	Sell	-22,867	Closed	-$160K	–	3202
2022 Q1	$160K	Buy	22,867 +523	+2%	+$5.34K	﹤0.01%	2802
2021 Q4	$302K	Sell	22,344 -416	-2%	-$6.61K	﹤0.01%	2701
2021 Q3	$384K	Buy	22,760 +995	+5%	+$21.1K	﹤0.01%	2670
2021 Q2	$634K	Sell	21,765 -2,282	-9%	-$71K	﹤0.01%	2448
2021 Q1	$946K	Buy	24,047 +13,798	+135%	+$448K	﹤0.01%	2214
2020 Q4	$233K	Buy	+10,249	New	+$257K	﹤0.01%	2772